Retatrutide, developed by Soma Pharmaceuticals , is gaining considerable attention as a innovative method for weight control . This unique medication merges the mechanism of a GLP-1 receptor stimulant and a GIP receptor agonist , aiming to simply promote reduced body fat but also target related metabolic factors. Initial clinical studies have indic